Olaparib in Metastatic Breast Cancer: The Impact of Prior Cyclin-Dependent Kinase 4 and 6 Inhibitor Exposure on Efficacy

J Jinyin Yan (Jinyin Yan, MD, PhD, Department of Breast Surgery, Tangshan Central Hospital, Tangshan City, China, Wei Xiong, MD, PhD, Department of Oncology, Tangshan People's Hospital, Tangshan City, China, Haifeng Cai, MD, PhD, Department of Breast Surgery, Tangshan People's Hospital, Tangshan City, China) W Wei Xiong H Haifeng Cai (Jinyin Yan, MD, PhD, Department of Breast Surgery, Tangshan Central Hospital, Tangshan City, China, Wei Xiong, MD, PhD, Department of Oncology, Tangshan People's Hospital, Tangshan City, China, Haifeng Cai, MD, PhD, Department of Breast Surgery, Tangshan People's Hospital, Tangshan City, China)

Article Details

Volume / Issue Vol. 1, Issue 1
Published July 07, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (3)

J

Jinyin Yan

Jinyin Yan, MD, PhD, Department of Breast Surgery, Tangshan Central Hospital, Tangshan City, China, Wei Xiong, MD, PhD, Department of Oncology, Tangshan People's Hospital, Tangshan City, China, Haifeng Cai, MD, PhD, Department of Breast Surgery, Tangshan People's Hospital, Tangshan City, China

W

Wei Xiong

H

Haifeng Cai

Jinyin Yan, MD, PhD, Department of Breast Surgery, Tangshan Central Hospital, Tangshan City, China, Wei Xiong, MD, PhD, Department of Oncology, Tangshan People's Hospital, Tangshan City, China, Haifeng Cai, MD, PhD, Department of Breast Surgery, Tangshan People's Hospital, Tangshan City, China